Publications:

Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes.

Leukemia

Follo, Matilde Y MY; Pellagatti, Andrea A; Armstrong, Richard N RN; Ratti, Stefano S; Mongiorgi, Sara S; De Fanti, Sara S; Bochicchio, Maria Teresa MT; Russo, Domenico D; Gobbi, Marco M; Miglino, Maurizio M; Parisi, Sarah S; Martinelli, Giovanni G; Cavo, Michele M; Luiselli, Donata D; McCubrey, James A JA; Suh, Pann-Ghill PG; Manzoli, Lucia L; Boultwood, Jacqueline J; Finelli, Carlo C; Cocco, Lucio L

Publication Date: 2019-09

Variant appearance in text: KIT: E562*

PubMed Link: 30787430

Variant Present in the following documents:

• Main text
• 41375_2019_Article_416.pdf

View BVdb publication page

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Heliyon

Deng, Qinfang Q; Xie, Boxiong B; Wu, Leilei L; Ji, Xianxiu X; Li, Chao C; Feng, Li L; Fang, Qiyu Q; Bao, Yuchen Y; Li, Jialu J; Jin, Shengnan S; Ding, Chunming C; Li, Yixue Y; Zhou, Songwen S

Publication Date: 2018-12

Variant appearance in text: KIT: E562X

PubMed Link: 30603682

Variant Present in the following documents:

• mmc2.xlsx, sheet 1

View BVdb publication page